Children aged 6-12 years achieved a 5.8% reduction in BMI with Novo Nordisk's Sa...
NanoSyrinx has secured £10m ($13m) aimed at advancing its technology for targete...
The US FDA has granted breakthrough therapy designation to Arrowhead Pharmaceuti...
After successfully completing two trials, SWIFT-1 and SWIFT-2, for its long-acti...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
Sildenafil citrate is under clinical development by XOMA Royalty and currently i...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
The atopic dermatitis market is facing increased growth, with a projected market...
A study suggests that children may face a higher risk of harm if their father is...
